Schroders’ Global Innovation trust bags 221% Carmot gain
Former Woodford Patient Capital receives $5.6m (£4.5m) from Roche’ s acquisition of Carmot Therapeutics, nine months after it invested $1.7m.
Investment company news brought to you by Citywire Financial Publishers Limited and Quoted Data by Marten & Co.
Refinancing risk sinks shares in Regional Reit
Shares in Regional Reit plunge 39% year to date as investors fret about office investor’s enlarged debt burden and falling occupancy.
Stock spotlight: Ashtead
Jonathan Mills from Metropolis Capital talks about his conviction in the equipment rental firm, Ashtead, which supplies a wide range of plant and comm...
QD view – Inflation Scare
With inflation rates much reduced, investors became convinced in October that interest rates had peaked. Share prices in the renewables and infrastruc...
On a 37% discount, Syncona sees first shoots of recovery from the biotech bear market
The listed life sciences fund posts a 5.4% gain for the last quarter, raising hopes of a turnaround after a tough six years.
Distressed Syncona sees first shoots of recovery from biotech bear market
The listed life sciences fund posts a 5.4% gain for the last quarter, raising hopes of a turnaround after a tough six years.
Polar Capital Global Financials affected by sector selloff
Polar capital Global Financials Trust says that its NAV total return for the year ended 30 November 2023 was -2.8%. This compares to a return on the M...
SEGRO capturing strong rental growth
SEGRO reported rental growth across its portfolio of 6.5% during 2023, as occupier demand for logistics space remained strong. Net rental income grew ...
QuotedData’s morning briefing 16 February 2024 – CHIU, INPP
In QuotedData’s morning briefing 16 February 2024: CT UK High Income Trust has decided to cancel the listing of its units (CHIU). Until now, investors...
QuotedData’s weekly news show 16th February 2024
Thank you to everyone that listened in today, whether you watched the Zoom live or on YouTube. In this week’s show, James Carthew covered the week’s t...
Schiehallion: Looking back, we invested at expensive valuations
Peter Singlehurst, Baillie Gifford's head of private companies and manager of its Schiehallion fund, admits ‘things got out of hand’ in early 2021 as valuations soared and what seemed cheap now looks dear.
‘Buy’: This real estate trust offers a double play on falling interest rates
Shares in the only London-listed pan-European real estate investment trust are trading on an attractive ‘double discount’.
